Crispr Therapeutics shares owned by Wealth Enhancement Advisory Services
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Wealth Enhancement Advisory Services
from 13F filings
Historical chart of Wealth Enhancement Advisory Services investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Wealth Enhancement Advisory Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.9M | 84k | 70.62 |
| 2025-06-30 | $4.3M | 83k | 52.17 |
| 2025-03-31 | $3.2M | 94k | 34.03 |
| 2024-12-31 | $1.1M | 27k | 39.36 |
| 2024-06-30 | $1.7M | 32k | 54.01 |
| 2024-03-31 | $931k | 14k | 68.16 |
| 2023-12-31 | $886k | 14k | 62.60 |
| 2023-09-30 | $471k | 10k | 45.39 |
More positions owned by Wealth Enhancement Advisory Services
View all positions for Wealth Enhancement Advisory Services